A Study of PD5K3 in Healthy Adult Volunteers

Summary

The main aim of this clinical trial is to assess the safety of PD5K3 in patients aged 18 to 65 years. The main questions it aims to answer are: * Is PD5K3 safe in adult? Researchers will compare PD5K3 to an active comparator pegaspargase to see if PD5K3 is safe and active in human. Participants will * Receive a single dose injection of PD5K3, pegaspargase or placebo according to weight, * Visit the clinic for assessment.

Timeline

Start

2023-11-27

Primary completion

2024-05-20

Completion

2024-05-20

Drugs

Indications